Furthermore, Parkar, Bhatt, and Addepalli [44] hypothesized that nobiletin, due to its metalloproteinase (MMP)-2- and MMP-9-inhibitory and antioxidant potential, could ameliorate the cardiovascular dysfunction in diabetes. The gene discussed is MMP9; the disease is diabetes mellitus.